Philippines - English - FDA (Food And Drug Administration)

zuellig pharma corporation; distributor: zuellig pharma corporation - brimonidine tartrate - sterile ophthamic solution - 1.5 mg/ml (0.15%)

Canada - English - Health Canada

pharmascience inc - brimonidine tartrate - solution - 0.2% - brimonidine tartrate 0.2% - alpha-adrenergic agonists

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

unimed sdn bhd - brimonidine tartrate -

Philippines - English - FDA (Food And Drug Administration)

ambica international corporation; distributor: ambica international corporation - brimonidine tartrate - ophthalmic solution - 1.5mg/ml (0.15%)

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

unimed sdn bhd - brimonidine tartrate -

New Zealand - English - Medsafe (Medicines Safety Authority)

miro healthcare limited - brimonidine tartrate 2 mg/ml equivalent to brimonidine 1.3 mg/ml - eye drops, solution - 2 mg/ml - active: brimonidine tartrate 2 mg/ml equivalent to brimonidine 1.3 mg/ml excipient: benzalkonium chloride citric acid monohydrate hydrochloric acid polyvinyl alcohol sodium chloride sodium citrate sodium hydroxide water for injection - indicated for lowering intraocular pressure in patients with chronic open-angle glaucoma or ocular hypertension.

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

lexon (uk) ltd - timolol maleate; brimonidine tartrate - eye drops - 5mg/1ml ; 2mg/1ml

United States - English - NLM (National Library of Medicine)

a-s medication solutions - brimonidine tartrate (unii: 4s9cl2dy2h) (brimonidine - unii:e6gnx3hhte) - brimonidine tartrate ophthalmic solution 0.2% is indicated for lowering intraocular pressure (iop) in patients with open-angle glaucoma or ocular hypertension. the iop lowering efficacy of brimonidine tartrate ophthalmic solution diminishes over time in some patients. this loss of effect appears with a variable time of onset in each patient and should be closely monitored. brimonidine tartrate ophthalmic solution is contraindicated in patients who have exhibited a hypersensitivity reaction to any component of this medication in the past [see adverse reactions (6.1) and (6.2)]. pregnancy category b: teratogenicity studies have been performed in animals. brimonidine tartrate was not teratogenic when given orally during gestation days 6 through 15 in rats and days 6 through 18 in rabbits. the highest doses of brimonidine tartrate in rats (2.5 mg/kg/day) and rabbits (5 mg/kg/day) achieved auc exposure values 375-fold higher or 19-fold higher, respectively, than similar values estimated in humans treated with brim

United States - English - NLM (National Library of Medicine)

a-s medication solutions - brimonidine tartrate (unii: 4s9cl2dy2h) (brimonidine - unii:e6gnx3hhte) - brimonidine tartrate ophthalmic solution, 0.2% is indicated for lowering intraocular pressure (iop) in patients with open-angle glaucoma or ocular hypertension. the iop lowering efficacy of brimonidine tartrate ophthalmic solution diminishes over time in some patients. this loss of effect appears with a variable time of onset in each patient and should be closely monitored. brimonidine tartrate ophthalmic solution is contraindicated in neonates and infants (under the age of 2 years) [see use in specific populations (8.4)]. brimonidine tartrate ophthalmic solution is contraindicated in patients who have exhibited a hypersensitivity reaction to any component of this medication in the past [see adverse reactions (6.1) and (6.2)]. teratogenicity studies have been performed in animals. brimonidine tartrate was not teratogenic when given orally during gestation days 6 through 15 in rats and days 6 through 18 in rabbits. the highest doses of brimonidine tartrate in rats (2.5 mg/kg/day) and rabbits (5 mg/kg/day) achi

New Zealand - English - Medsafe (Medicines Safety Authority)

miro healthcare limited - brimonidine tartrate 2 mg/ml; timolol maleate 6.8 mg/ml equivalent to timolol 5mg/ml - eye drops, solution - active: brimonidine tartrate 2 mg/ml timolol maleate 6.8 mg/ml equivalent to timolol 5mg/ml excipient: benzalkonium chloride dibasic sodium phosphate heptahydrate hydrochloric acid monobasic sodium phosphate monohydrate sodium hydroxide water for injection - brimonidine timolol indoco is indicated for the reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension not adequately responding to monotherapy.